Injectable biomaterial shuttles for cell therapy in stroke.

Area of Science:

• Neuroscience
• Biomaterials Science
• Regenerative Medicine

Background:

• Ischemic stroke (IS) is a major cause of disability and socio-economic burden.
• Brain repair strategies, including cell therapy, face challenges due to brain complexity.
• Biomaterials can overcome these hurdles by providing structural support and modulating the brain environment.

Purpose of the Study:

• To review the significance and challenges of cell therapy for ischemic brain repair.
• To explore biomaterial-based delivery systems for enhanced cell therapy in IS.
• To discuss the role of biomaterials in supporting transplanted cell survival and integration.

Main Methods:

• Review of pre-clinical research on cell therapy and biomaterial interventions for ischemic stroke.
• Analysis of biomaterial design principles for sustained drug delivery and cell support.
• Examination of biological responses to biomaterials and strategies for modulation.

Main Results:

• Biomaterials can provide structural support, localization, and immunomodulation for brain repair.
• Biomaterial-based systems facilitate sustained trophic factor delivery and enhance transplanted cell survival.
• Modulating biological responses to biomaterials is crucial for therapeutic success.

Conclusions:

• Biomaterial interventions are promising for enhancing cell therapy in ischemic stroke treatment.
• A combination of material design and disease biology is essential for effective biomaterial-based stroke interventions.
• Future research should focus on integrated approaches for advanced biomaterial therapies.